Risks and Returns of Aptose Biosciences Inc (APTO) Stock
Cantor Fitzgerald raised the price target for the Aptose Biosciences Inc (NASDAQ:APTO) stock to “an Overweight”. The rating was released on October 19, 2020, according to finviz. The research report from Maxim Group has initiated the stock to Buy, with a price target set at $16. The stock was reiterated by H.C. Wainwright, who disclosed […]
